The anti-IL1RAP antibody CAN04 increases tumor sensitivity to platinum-based chemotherapy

Millrud, CR; von Wachenfeldt, K; Falk, HH; Forsberg, G; Liberg, D

CANCER RESEARCH, 2020; 80 (16):